Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
GNLX Genelux
- 2.550
- -0.130-4.85%
Close Jan 8 16:00 ET
- 2.550
- 0.0000.00%
Post 20:01 ET
88.07MMarket Cap-3.18P/E (TTM)
2.690High2.550Low42.63KVolume2.670Open2.680Pre Close110.83KTurnover0.16%Turnover RatioLossP/E (Static)34.54MShares13.97052wk High2.66P/B67.37MFloat Cap1.60052wk Low--Dividend TTM26.42MShs Float40.980Historical High--Div YieldTTM5.22%Amplitude1.600Historical Low2.599Avg Price1Lot Size
About Genelux Company
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
Company Profile
SymbolGNLX
Company NameGenelux
Listing DateJan 26, 2023
Issue Price6.00
Founded2001
CEOMr. Thomas Zindrick, J.D.
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address2625 Townsgate Road,Suite 230
CityWestlake Village
ProvinceCalifornia
CountryUnited States of America
Zip Code91361
Phone1-858-267-9889
Websitehttp://www.genelux.com
Company Executives
- Name
- Position
- Salary
- Thomas Zindrick, J.D.
- Chairman of the Board, President and Chief Executive Officer
- 6.20M
- Lourie S. Zak
- Chief Financial Officer and Principal Accounting Officer
- 2.83M
- Dr. Paul Scigalla, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Joseph Cappello, PhD
- Chief Technical Officer
- --
- Dr. Tony Yu, PhD
- Senior Vice President, Clinical Development
- --
- Mary Mirabelli
- Independent Director
- 222.07K
- James L. Tyree
- Lead Independent Director
- 284.13K
- Dr. John Thomas, PhD
- Independent Director
- 278.13K
- John W. Smither
- Independent Director
- 328.62K
- Sean Ryder, J.D.
- General Counsel and Corporate Secretary
- --
- Ralph Smalling
- Head, Regulatory
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.